The ubiquitin-proteasome pathway regulates claudin 5 degradation

Journal of Cellular Biochemistry

Volumn 113, Issue 7, 2012, Pages 2415-2423

  Mandel, Ilana ^a   Paperna, Tamar ^a   Volkowich, Anat ^a   Merhav, Maayan ^a   Glass Marmor, Lea ^a   Miller, Ariel ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Claudin; proteasome; tight junctions; UBIQUITIN

Indexed keywords

CLAUDIN 5; LYSINE; PROTEASOME; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; DEGRADATION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UBIQUITINATION;

CELL LINE, TUMOR; CLAUDINS; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MEMBRANE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; TIGHT JUNCTIONS; UBIQUITIN; UBIQUITINATION;

EID: 84861040091     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24118     Document Type: Article

References (39)

1. Angelow S, Ahlstrom R, Yu AS,. 2008. Biology of claudins. Am J Physiol Renal Physiol 295: F867-F876.
2. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR,. 2009. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 106: 1977-1982.
3. Asaka M, Hirase T, Hashimoto-Komatsu A, Node K,. 2011. Rab5a-mediated localization of claudin-1 is regulated by proteasomes in endothelial cells. Am J Physiol Cell Physiol 300: C87-C96.
4. Aslam M, Ahmad N, Srivastava R, Hemmer B,. 2012. TNF-alpha induced NFkappaB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells. Cytokine 57: 269-275.
5. Ben-Yosef Y, Miller A, Shapiro S, Lahat N,. 2005. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol 289: C1321-C1331.
6. Bianchi K, Meier P,. 2009. A tangled web of ubiquitin chains: Breaking news in TNF-R1 signaling. Mol Cell 36: 736-742.
7. Caraglia M, Marra M, Pelaia G, Maselli R, Caputi M, Marsico SA, Abbruzzese A,. 2005. Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 202: 323-335.
8. Chiba H, Osanai M, Murata M, Kojima T, Sawada N,. 2008. Transmembrane proteins of tight junctions. Biochim Biophys Acta 1778: 588-600.
9. Dupre DJ, Chen Z, Le Gouill C, Theriault C, Parent JL, Rola-Pleszczynski M, Stankova J,. 2003. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor. J Biol Chem 278: 48228-48235.
10. Elliott PJ, Zollner TM, Boehncke WH,. 2003. Proteasome inhibition: A new anti-inflammatory strategy. J Mol Med 81: 235-245.
11. Felinski EA, Cox AE, Phillips BE, Antonetti DA,. 2008. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. Exp Eye Res 86: 867-878.
12. Forster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D,. 2008. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol 586: 1937-1949.
13. Gonzalez-Mariscal L, Tapia R, Chamorro D,. 2008. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-756.
14. Guillemot L, Paschoud S, Pulimeno P, Foglia A, Citi S,. 2008. The cytoplasmic plaque of tight junctions: A scaffolding and signalling center. Biochim Biophys Acta 1778: 601-613.
15. Haglund K, Sigismund S, Polo S, Szymkiewicz I, Di Fiore PP, Dikic I,. 2003. Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol 5: 461-466.
16. Herve JC, Derangeon M, Bahbouhi B, Mesnil M, Sarrouilhe D,. 2007. The connexin turnover, an important modulating factor of the level of cell-to-cell junctional communication: Comparison with other integral membrane proteins. J Membr Biol 217: 21-33.
17. Kay BK, Williamson MP, Sudol M,. 2000. The importance of being proline: The interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 14: 231-241.
18. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE,. 2008. Structure and function of claudins. Biochim Biophys Acta 1778: 631-645.
19. Mandel I, Paperna T, Glass-Marmor L, Volkowich A, Badarny S, Schwartz I, Vardi P, Koren I, Miller A,. 2011. Tight junction proteins expression and modulation in immune cells and multiple sclerosis. J Cell Mol Med [epub ahead of print]. DOI: 10.1111/j.1582-4934.2011.01380.x
20. Matsuda M, Kubo A, Furuse M, Tsukita S,. 2004. A peculiar internalization of claudins, tight junction-specific adhesion molecules, during the intercellular movement of epithelial cells. J Cell Sci 117: 1247-1257.
21. Matter K, Aijaz S, Tsapara A, Balda MS,. 2005. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 17: 453-458.
22. Miranda M, Sorkin A,. 2007. Regulation of receptors and transporters by ubiquitination: New insights into surprisingly similar mechanisms. Mol Interv 7: 157-167.
23. Murakami T, Felinski EA, Antonetti DA,. 2009. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 284: 21036-21046.
24. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S,. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161: 653-660.
25. Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T,. 2006. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 107: 4770-4780.
26. Rocca A, Lamaze C, Subtil A, Dautry-Varsat A,. 2001. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments. Mol Biol Cell 12: 1293-1301.
27. Ronaldson PT, Demarco KM, Sanchez-Covarrubias L, Solinsky CM, Davis TP,. 2009. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J Cereb Blood Flow Metab 29: 1084-1098.
28. Ruffer C, Gerke V,. 2004. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol 83: 135-144.
29. Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, Mehanna A, Risso JJ, Chauvin JP, Fenouillet E, Rivera S, Khrestchatisky M,. 2010. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia 58: 344-366.
30. Schaheen B, Dang H, Fares H,. 2009. Derlin-dependent accumulation of integral membrane proteins at cell surfaces. J Cell Sci 122: 2228-2239.
31. Schakman O, Gilson H, Kalista S, Thissen JP,. 2009. Mechanisms of muscle atrophy induced by glucocorticoids. Horm Res 72 (Suppl 1): 36-41.
32. Staub O, Rotin D,. 2006. Role of ubiquitylation in cellular membrane transport. Physiol Rev 86: 669-707.
33. Takahashi S, Iwamoto N, Sasaki H, Ohashi M, Oda Y, Tsukita S, Furuse M,. 2009. The E3 ubiquitin ligase LNX1p80 promotes the removal of claudins from tight junctions in MDCK cells. J Cell Sci 122: 985-994.
34. Takino T, Miyamori H, Kawaguchi N, Uekita T, Seiki M, Sato H,. 2003. Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. Biochem Biophys Res Commun 304: 160-166.
35. Traweger A, Fang D, Liu YC, Stelzhammer W, Krizbai IA, Fresser F, Bauer HC, Bauer H,. 2002. The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itch. J Biol Chem 277: 10201-10208.
36. Van Itallie CM, Colegio OR, Anderson JM,. 2004. The cytoplasmic tails of claudins can influence tight junction barrier properties through effects on protein stability. J Membr Biol 199: 29-38.
37. Weissman AM, Shabek N, Ciechanover A,. 2011. The predator becomes the prey: Regulating the ubiquitin system by ubiquitylation and degradation. Nat Rev Mol Cell Biol 12: 605-620.
38. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA,. 2007. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27: 697-709.
39. Zlokovic BV,. 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.